Cabaletta Bio, Inc.

NASDAQ:CABA

4 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 004.0100000000000000000000000
Cost of Revenue 0.4260.3930.3360.3550.8330.8172.8640.3630.2380.2190.2340.2210.1620.116000000000000
Gross Profit -0.426-0.3933.674-0.355-0.833-0.817-2.864-0.363-0.238-0.219-0.234-0.221-0.162-0.116000000000000
Gross Profit Ratio 000.91600000000000000000000000
Reseach & Development Expenses 23.42721.95417.40513.78711.79712.43512.48.2169.5149.179.9198.1697.856.5565.7755.655.3314.623.0263.222.6642.7611.2392.5890.320.32
General & Administrative Expenses 6.8526.0775.7414.8814.0934.5213.9023.5623.5463.8293.9743.3943.2953.1563.5552.7662.8613.2752.8341.8111.1381.2290.8260.4910.2050.205
Selling & Marketing Expenses -0.426-0.393-0.33600000000000000000000000
SG&A 6.4265.6845.4054.8814.0934.5213.9023.5623.5463.8293.9743.3943.2953.1563.5552.7662.8613.2752.8341.8111.1381.2290.8260.4910.2050.205
Other Expenses 00000000000000000000000-6.24400
Operating Expenses 29.85327.63822.8118.66815.8916.95616.30211.77813.0612.99913.89311.56311.1459.7129.338.4168.1927.8955.865.0313.8023.992.0653.080.5240.524
Operating Income -30.279-28.031-23.146-18.668-15.89-16.956-16.302-11.778-13.06-12.999-13.893-11.563-11.145-9.712-9.33-8.416-8.192-7.895-5.86-5.031-3.802-3.99-2.065-3.08-0.524-0.524
Operating Income Ratio 00-5.77200000000000000000000000
Total Other Income Expenses Net 2.6772.9842.262.221.4031.1020.610.3510.150.0530.0050.0030.0060.010.0210.0230.040.410.4570.3810.4440.4580.16-6.2440.0140.014
Income Before Tax -27.602-25.047-20.886-16.448-14.487-15.854-15.692-11.427-12.91-12.946-13.888-11.56-11.139-9.702-9.309-8.393-8.152-7.485-5.403-4.65-3.358-3.532-1.905-9.276-0.511-0.511
Income Before Tax Ratio 00-5.20800000000000000000000000
Income Tax Expense 00.351.457-0.3550.248-1.102-0.813-0.351-0.15-0.053-0.234000-0.11000-0.05100-3.99-2.065-3.1280.0140.014
Net Income -27.602-25.047-20.886-16.448-14.487-14.752-14.879-11.076-12.76-12.893-13.888-11.56-11.139-9.702-9.309-8.393-8.152-7.485-5.403-4.65-3.358-3.532-1.905-9.276-0.511-0.511
Net Income Ratio 00-5.20800000000000000000000000
EPS -0.56-0.51-0.47-0.37-0.37-0.42-0.51-0.38-0.44-0.45-0.49-0.45-0.55-0.51-0.4-0.36-0.35-0.33-0.22-0.21-0.23-0.24-0.52-0.64-0.22-0.22
EPS Diluted -0.56-0.51-0.47-0.37-0.37-0.42-0.51-0.38-0.44-0.45-0.49-0.45-0.45-0.41-0.4-0.36-0.35-0.33-0.22-0.21-0.23-0.24-0.52-0.64-0.22-0.22
EBITDA -29.853-27.638-22.81-18.668-15.52-16.591-16.302-11.415-12.822-12.78-13.893-11.342-10.983-9.596-9.33-8.326-8.114-7.819-5.86-4.999-3.781-3.99-2.065-3.080.0140.014
EBITDA Ratio 00-5.68800000000000000000000000